Evidence map›Paper›PMID 37408483›Full record

ArticleJournal of the International AIDS Society2023

Clients in Uganda accessing preferred differentiated antiretroviral therapy models achieve higher viral suppression and are less likely to miss appointments: a cross-sectional analysis.

Esther K Karamagi Nkolo, Jessica Clinkscales Ejike, Simon Sensalire, Juliana Nabwire Ssali, Immaculate Ddumba, Jacqueline Calnan, Carolina Gonzalez, Nelly Maina, Melaku Dessie, Lauren Bailey and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Esther K Karamagi NkoloU.S. Agency for International Development (USAID), Kampala, Uganda.ORCID 0000-0001-6865-9555
Jessica Clinkscales EjikeGHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Simon SensalireUniversity Research Co., LLC, USAID RHITES N-Acholi Activity Kampala, Kampala, Uganda.
Juliana Nabwire SsaliUniversity Research Co., LLC, USAID RHITES N-Acholi Activity Kampala, Kampala, Uganda.
Immaculate DdumbaU.S. Agency for International Development (USAID), Kampala, Uganda.ORCID 0000-0003-3555-0312
Jacqueline CalnanU.S. Agency for International Development (USAID), Kampala, Uganda.
Carolina GonzalezGHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Nelly MainaGHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Melaku DessieU.S. Agency for International Development (USAID), Office of HIV/AIDS, Prevention Care and Treatment Division, Washington, DC, USA.
Lauren BaileyGHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Ugochukwu AmanyeiweGHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Thomas MiniorU.S. Agency for International Development (USAID), Office of HIV/AIDS, Prevention Care and Treatment Division, Washington, DC, USA.
Karishma SrikanthGHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Herbert KadamaMinistry of Health, AIDS Control Program, Kampala, Uganda.
Khushi PatelBrown University [USAID Intern], Providence, Rhode Island, USA.
Dina PatelGHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.ORCID 0000-0002-8936-7356
United States Agency for International Development · USKampala University · UGBrown University · USMinistry of Health · UG

Funding

PEPFAR
6 · The paper itself

Abstract

introductionThe Uganda Ministry of Health recommends facility- and community-based differentiated antiretroviral therapy (DART) models to support person-centred care for eligible clients receiving antiretroviral therapy (ART). Healthcare workers assess client eligibility for one of six DART models upon initial enrolment; however, client circumstances evolve, and their preferences are not routinely adjusted. We developed a tool to understand the proportion of clients accessing preferred DART models and compared the outcomes of clients accessing preferred DART models to the outcomes of clients not receiving preferred DART models.

methodsWe conducted a cross-sectional study. A sample of 6376 clients was selected from 113 referrals, general hospitals and health centres purposely selected from 74 districts. Clients receiving ART accessing care from the sampled sites were eligible for inclusion. Healthcare workers interviewed clients (caretakers of clients under 18), over a 2-week period between January and February 2022 using a client preference tool to elicit whether clients were receiving DART services through their preferred model. Treatment outcomes of viral load test, viral load suppression and missed appointment date were extracted from clients' medical files before or immediately after the interview and de-identified. The descriptive analysis determined the interaction between client preferences and predefined treatment outcomes by comparing outcomes of clients whose care aligned with their preferences to outcomes of clients whose care misaligned with their preferences.

resultsOf 25% (1573/6376) of clients not accessing their preferred DART model, 56% were on facility-based individual management and 35% preferred fast-track drug refills model. Viral load coverage was 87% for clients accessing preferred DART models compared to 68% among clients not accessing their preferred model. Viral load suppression was higher among clients who accessed the preferred DART model (85%) compared to (68%) clients who did not access their preferred DART model. Missed appointments were lower at 29% for clients who accessed preferred DART models compared to 40% among clients not enrolled in the DART model of their choice.

conclusionsClients who accessed their preferred DART model have better clinical outcomes. Preferences should be integrated throughout health systems, improvement interventions, policies and research efforts to ensure client-centred care and client autonomy.

Indexed as

Anti-HIV AgentsHIV InfectionsCross-Sectional StudiesHealth FacilitiesHumansUgandaAnti-HIV AgentsARTclient preferenceDARTmissed appointmentUgandaviral load suppression

Identifiers

PMID37408483
PMCPMC10323312
OpenAlexW4383302222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.